| Literature DB >> 26247671 |
Carla Augusto Holms1, Denise Aya Otsuki1, Marcia Kahvegian1, Cristina Oliveira Massoco2, Denise Tabacchi Fantoni3, Paulo Sampaio Gutierrez1, Jose Otavio Costa Auler Junior1.
Abstract
OBJECTIVES: Hypertonic saline has been proposed to modulate the inflammatory cascade in certain experimental conditions, including pulmonary inflammation caused by inhaled gastric contents. The present study aimed to assess the potential anti-inflammatory effects of administering a single intravenous dose of 7.5% hypertonic saline in an experimental model of acute lung injury induced by hydrochloric acid.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26247671 PMCID: PMC4518820 DOI: 10.6061/clinics/2015(08)08
Source DB: PubMed Journal: Clinics (Sao Paulo) ISSN: 1807-5932 Impact factor: 2.365
Figure 1Study design.
Hemodynamics and respiratory variables in the control (SHAM and hypertonic saline) and acid lesion (acute lung injury and acute lung injury + hypertonic saline) groups.
| Variable | Group | BL | T30 | T90 | T150 | T210 | T270 |
|---|---|---|---|---|---|---|---|
| CI (L/min/m2) | SHAM | 3.6±0.6 | 3.7±0.5 | 4.0±0.5 | 4.3±0.5 | 4.3±0.7 | 4.3±0.7 |
| HS | 3.7±0.3 | 4.1±0.4 | 4.9±0.4 | 4.9±0.6 | 4.6±0.7 | 4.5±0.7 | |
| ALI | 3.9±0.6 | 4.2±0.9 | 4.4±0.9 | 4.4±0.8 | 4.2±0.7 | 4.2±0.5 | |
| ALI+HS | 3.5±0.3 | 4.3±0.4 | 4.8±0.5 | 4.8±0.4 | 4.8±0.4 | 4.6±0.5 | |
| HR (bpm) | SHAM | 94±8 | 97±11 | 101±19 | 104±15 | 107±21 | 108±28 |
| HS | 104±15 | 105±11 | 115±15 | 129±18 | 122±18 | 117±10 | |
| ALI | 106±13 | 124±15 | 112±19 | 122±31 | 119±30 | 119±21 | |
| ALI+HS | 92±12 | 114±13 | 120±21 | 121±12 | 124±17 | 121±19 | |
| MAP (mmHg) | SHAM | 54±7 | 59±6 | 69±10 | 66±12 | 61±9 | 61±8 |
| HS | 67±3 | 72±4 | 84±10 | 81±12 | 76±9 | 77±7 | |
| ALI | 70±8 | 80±16 | 80±8 | 84±9 | 82±8 | 81±5 | |
| ALI+HS | 66±3 | 83±17 | 83±11 | 85±11 | 85±12 | 82±8 | |
| MPAP (mmHg) | SHAM | 14±2 | 16±2 | 15±3 | 15±3 | 16±3 | 15±2 |
| HS | 16±2 | 16±1 | 19±1 | 16±6 | 18±2** | 19±2 | |
| ALI | 16±2 | 25±3 | 19±3 | 22±3 | 21±3 | 22±4 | |
| ALI+HS | 14±3 | 26±5 | 21±3 | 24±3 | 24±4 | 23±3 | |
| CVP (mmHg) | SHAM | 9±3 | 11±2 | 10±3 | 10±3 | 10±2 | 10±2 |
| HS | 10±2 | 11±1 | 11±1 | 10±1 | 10±2 | 10±2 | |
| ALI | 10±1 | 9±1 | 10±1 | 10±1 | 10±1 | 10±1 | |
| ALI+HS | 9±1 | 11±1 | 9±1 | 10±1 | 10±1 | 10±1 | |
| PVRI (dyne.sec.cm−5.m2) | SHAM | 131±20 | 129±18 | 121±16 | 131±30 | 132±28 | 131±30 |
| HS | 128±15 | 119±30 | 130±40 | 130±27 | 132±31 | 149±28 | |
| ALI | 152±31 | 331±114 | 225±51 | 266±77 | 230±58 | 290±51 | |
| ALI+HS | 137±35 | 364±127 | 207±57 | 266±53 | 266±66 | 263±58 | |
| SVRI (dyne.sec.cm−5.m2) | SHAM | 1317±188 | 1249±138 | 1348±158 | 1302±236 | 1362±202 | 1274±111 |
| HS | 1185±124 | 1178±140 | 1157±202 | 1115±200 | 1116±228 | 1172±272 | |
| ALI | 1228±152 | 1343±335 | 1317±354 | 1372±320 | 1419±352 | 1375±187 | |
| ALI+HS | 1266±175 | 1349±291 | 1222±254 | 1247±280 | 1251±274 | 1241±269 | |
| PPlat (cmH2O) | SHAM | 13±1 | 14±1 | 14±1.7 | 14±1.6 | 14±1.6 | 14±1.6 |
| HS | 14±1 | 14±1,8 | 14±1.8 | 15±1.6 | 15±1.9 | 15±2 | |
| ALI | 14±1 | 23±1.3 | 21±1.5 | 21±1.7 | 21±1.8 | 21±1.7 | |
| ALI+HS | 14±1 | 23±1.6 | 21±1.7 | 21±1.6 | 21±1.2 | 21±1.2 | |
| Compl (cmH2O) | SHAM | 31±4.1 | 30±4.5 | 29±4 | 29±4.3 | 28±4 | 28±3.6 |
| HS | 29±4.5 | 28±4.6 | 26±3.8 | 26±3.8 | 25±4.4 | 24±4.3 | |
| ALI | 28±4.2 | 14±1.4 | 16±2 | 16±1.9 | 16±1.5 | 16±2.5 | |
| ALI+HS | 28±4.2 | 13±2 | 15±1.6 | 15±1.7 | 15±1.7 | 15±2 |
Data are expressed as the mean±standard deviation. CI: cardiac index; HR: heart rate; MAP: mean arterial pressure; MPAP: mean pulmonary arterial pressure; CVP: central venous pressure; PVRI: pulmonary vascular resistance index; SVRI: systemic vascular resistance index; PPlat: plateau pressure; Compl: pulmonary compliance;
*p<0.05 compared with the baseline;
*p<0.01 compared with the Sham group;
# p<0.05 compared with the HS group.
Figure 2Changes in the PaO2/FiO2 ratio in the control (Sham and HS) and acid-lesion (acute lung injury and AI + hypertonic saline) groups. *: p<0.05 compared with TB; †: p<0.05 compared with the Sham group; #: p<0.05 compared with the hypertonic saline group.
Figure 3Bronchoalveolar lavage cytokines. The values are expressed in pg/ml. Data are presented as the group mean±SD. †: p<0.05 compared with the Sham group; #: p<0.05 compared with the hypertonic saline group; §: p<0.05 compared with the acute lung injury group.
Figure 4Scores for histological injury of the lungs. †: p<0.05 compared with the Sham group; #: p<0.05 compared with the hypertonic saline group.
Figure 5Representative photomicrographs with hematoxylin and eosin (H&E) staining (x200) of the lungs of pigs submitted to acute lung injury. A) Sham group. B) hypertonic saline group. C) acute lung injury group. D) acute lung injury + hypertonic saline group. Extensive alveolar and interstitial inflammatory infiltration was seen in both injury groups.